Xing Zhong Wu

Xing Zhong Wu

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CJCheng You Jia
Cheng You Jia
HLHui Hui Li
Hui Hui Li
XZXu Chao Zhu
Xu Chao Zhu
YDYi Wei Dong
Yi Wei Dong
DFDa Fu
Da Fu
XWXing Zhong Wu
Xing Zhong Wu
To study the roles of microRNA-223 (miR-223) in regulation of cell growth, we established a miR-223 over-expression model in HeLa cells infected with miR-223 by Lentivirus pLL3.7 system. We observed in this model that miR-223 significantly suppressed the proliferation, growth rate, colony formation of HeLa cells in vitro, and in vivo tumorigenicity or tumor formation in nude mice. To investigate the mechanisms involved, we scanned and examined the potential and putative target molecules of miR-223 by informatics, quantitative PCR and Western blot, and found that insulin-like growth factor-1 receptor (IGF-1R) was the functional target of miR-223 inhibition of cell proliferation. Targeting IGF-1R by miR-223 was not only seen in HeLa cells, but also in leukemia and hepatoma cells. The downstream pathway, Akt/mTOR/p70S6K, to which the signal was mediated by IGF-1R, was inhibited as well. The relative luciferase activity of the reporter containing wild-type 3′UTR(3′untranslated region) of IGF-1R was significantly suppressed, but the mutant not. Silence of IGF-1R expression by vector-based short hairpin RNA resulted in the similar inhibition with miR-223. Contrarily, rescued IGF-1R expression in the cells that over-expressed miR-223, reversed the inhibition caused by miR-223 via introducing IGF-1R cDNA that didn't contain the 3′UTR. Meanwhile, we also noted that miR-223 targeted Rasa1, but the downstream molecules mediated by Rasa1 was neither targeted nor regulated. Therefore we believed that IGF-1R was the functional target for miR-223 suppression of cell proliferation and its downstream PI3K/Akt/mTOR/p70S6K pathway suppressed by miR-223 was by targeting IGF-1R.

1 October 2004 in Cell Research
Verified
Journal Article
Closed access
FGFei Geng
Fei Geng
BSBi Zhi Shi
Bi Zhi Shi
YYYun Feng Yuan
Yun Feng Yuan
XWXing Zhong Wu
Xing Zhong Wu

25 September 2012 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
XZXu-Chao Zhu
Xu-Chao Zhu
QDQiong-Zhu Dong
Qiong-Zhu Dong
XZXiao-Fei Zhang
Xiao-Fei Zhang
BDBiao Deng
Biao Deng
HJHu-Liang Jia
Hu-Liang Jia
XWXing Zhong Wu
Xing Zhong Wu
In the present study, we constructed a lentivirus vector encoding the miR-29a precursor and established two stably infected cell lines, PLC-29a and 97L-29a. The overexpression of miR-29a was confirmed by TaqMan RT-PCR and significantly suppressed the growth of the hepatocellular carcinoma cell lines MHCC-97L and PLC. Dual-luciferase reporter assays indicated that the SPARC mRNA 3'UTR was directly targeted by miR-29a since the mutated 3'UTR was not affected. Silencing SPARC expression by RNAi knockdown resulted in a similar effect as miR-29a overexpression on hepatocellular carcinoma (HCC) cell growth regulation. Anti-miR-29a oligonucleotides (AMOs) upregulated the levels of SPARC in the HCC cells. The phosphorylation of AKT/mTOR downstream of SPARC was inhibited in miR-29a-overexpressing HCC cells. We further examined and compared the expression levels of miR-29a in HCC tissues and the corresponding nearby non-cancerous liver tissues of 110 patients with HCC by qRT-PCR, and significantly lower expression of miR-29a was observed in the tissues affected by HCC. Our findings demonstrate that the expression of miR-29a is important in the regulation of the SPARC-AKT pathway and HCC growth.

1 January 2019 in Theranostics
Verified
Journal Article
Open access
CKChun Lan Kang
Chun Lan Kang
BQBing Qi
Bing Qi
QCQian Qian Cai
Qian Qian Cai
LFLi Sheng Fu
Li Sheng Fu
YYYing Yang
Ying Yang
XWXing Zhong Wu
Xing Zhong Wu
Rationale: Tumor metastasis is the main cause for cancer-related death. However, the driving molecules of metastasis remain largely unknown. Here, we aim to identify long non-coding RNAs (lncRNAs) critical for human hepatocellular carcinoma (HCC) metastasis.

1 April 2014 in Journal of Hepatology
Verified
Journal Article
Closed access
YDYi Wei Dong
Yi Wei Dong
RWRong Wang
Rong Wang
QCQian Qian Cai
Qian Qian Cai
BQBing Qi
Bing Qi
WWWei Wu
Wei Wu
XWXing Zhong Wu
Xing Zhong Wu

18 December 2013 in Molecular Oncology
Verified
Journal Article
Open access
YJYing Jing
Ying Jing
DJDeshui Jia
Deshui Jia
Chun-Ming WongChun-Ming Wong
Chun-Ming Wong
INIrene Oi Lin Ng
Irene Oi Lin Ng
ZZZhenfeng Zhang
Zhenfeng Zhang
XHXianghuo He
Xianghuo He
In our previous study, we identified 1241 loci with somatic copy number alterations in human hepatocellular carcinoma (HCC) using Affymetrix SNP 6.0 arrays, and a putative cancer gene SERPINA5 was uncovered in a novel chromosomal region with recurrent copy number loss at 14q31.1–32.13. The SERPINA5 was reported to be deregulated in renal, breast, prostate and ovarian cancers. However, the roles of SERPINA5 in cancer remain greatly elusive. In this study, we found that the DNA dosage and expression level of the SERPINA5 gene were significantly decreased in HCC by quantitative real‐time PCR. Notably, the expression levels of SERPINA5 negatively correlated with malignant progression of HCC. The SERPINA5 gene was further observed to reduce in vitro and in vivo metastatic potential of HCC cells. Moreover, secreted SERPINA5 protein also could inhibit the metastatic ability of HCC cells. Finally, we discovered that one of the mechanisms explaining SERPINA5 inhibition of HCC metastasis is through direct interaction with fibronectin and disruption of the fibronectin–integrin signaling pathway. These findings highlight an important role of SERPINA5 in the regulation of migratory and metastatic potentials of HCC and suggest a potential application of SERPINA5 in cancer treatment.